8 of 8
MALEKI ET AL.
[4] A. C. Gaudio, A. Korokovas, Y. Takahata, J. Pharm. Sci. 1994,
83, 1110.
J = 7.2 Hz, CH3), 2.26 (3H, s, CH3), 2.22‐2.34 (4H, m,
2CH2), 2.38 (3H, s, CH3), 4.16 (2H, q, J = 7.2 Hz,
OCH2), 5.43 (1H, s, CH), 6.19 (1H, br s, NH); 6.84 (2H,
d, J = 7.5 Hz, H‐Ar), 7.03 (2H, d, J = 7.5 Hz, H‐Ar). Anal.
Calcd for C22H27NO3: C, 74.76; H, 7.70; N, 3.96. Found: C,
74.71; H, 7.66; N, 4.03.
[5] P. P. Mager, R. A. Coburn, A. J. Solo, D. J. Triggle, H. Rothe,
QSAR, Drug Des. Disc. 1992, 8, 273.
[6] M. F. Gordeev, D. V. Patel, E. M. Gordon, J. Org. Chem. 1996,
61, 924.
[7] R. Miri, H. Niknahad, G. Vesal, A. Shafiee, IL Farmaco 2002,
57, 123.
4.4.2 | Ethyl 4‐(4‐chlorophenyl)‐2,7,7‐
trimethyl‐5‐oxo‐1,4,5,6,7,8‐hexahydroquino-
line‐3‐carboxylate (5d)
[8] A. Dondoni, A. Massi, E. Minghini, S. Sabbatini, V. Bertoasi,
J. Org. Chem. 2003, 68, 6172.
[9] M. Poliakoff, P. Licence, Nature 2007, 450, 810.
IR (KBr) (υmax, cm‐1) = 3274, 3205, 3076, 2960, 1704, 1647,
1604, 1488, 1380, 1278, 1215, 1070. H NMR (300 MHz,
[10] A. Maleki, E. Akhlaghi, R. Paydar, Appl. Organometal. Chem.
2016, 30, 382.
1
CDCl3): δH (ppm) = 0.93 (3H, s, CH3), 1.08 (3H, s, CH3),
1.20 (3H, t, J = 7.1 Hz, CH3), 2.06‐2.31 (4H, m, 2CH2),
2.38 (3H, s, CH3), 4.06 (2H, q, J = 7.1 Hz, OCH2), 5.03
(1H, s, CH), 6.23 (1H, br s, NH), 7.16 (2H, d, J = 8.1 Hz,
H‐Ar), 7.26 (2H, d, J = 8.4 Hz, H‐Ar). Anal. Calcd for
C21H24ClNO3: C, 67.46; H, 6.47; N, 3.75. Found: C,
67.32; H, 6.54; N, 3.82.
[11] A. Maleki, M. Aghaei, N. Ghamari, Appl. Organometal. Chem.
2016, 30, 939.
[12] A. Maleki, M. Kamalzare, Catal. Commun. 2014, 53, 67.
[13] A. Maleki, M. Aghaei, N. Ghamari, Chem. Lett. 2015, 44, 259.
[14] M. A. Zolfigol, R. Ayazi‐Nasrabadi, S. Baghery, Appl.
Organometal. Chem. 2016, 30, 273.
[15] A. Maleki, Ultrason. Sonochem. 2018, 40, 460.
[16] A. Maleki, S. Azadegan, Inorg. Nano‐Met. Chem. 2017, 47,
917.
4.4.3 | Ethyl 2,7,7‐trimethyl‐5‐oxo‐4‐
(thiophen‐2‐yl)‐1,4,5,6,7,8‐hexahydroquino-
line‐3‐carboxylate (5n)
[17] A. Maleki, M. Aghaei, R. Paydar, J. Iran. Chem. Soc. 2017, 14,
485.
[18] A. Maleki, Tetrahedron Lett. 2013, 54, 2055.
[19] A. Maleki, RSC Adv. 2014, 4, 64169.
IR (KBr) (υmax, cm‐1) = 3274, 3207, 2960, 1701, 1647, 1604,
1
1492, 1379, 1215, 1072. H NMR (300 MHz, CDCl3): δH
[20] A. Maleki, R. Rahimi, S. Maleki, N. Hamidi, RSC Adv. 2014, 4,
(ppm) = 1.04 (3H, s, CH3), 1.10 (3H, s, CH3), 1.27 (3H, t,
J = 7.1 Hz, CH3), 2.22‐2.34 (4H, m, 2CH2), 2.38 (3H, s,
CH3), 4.16 (2H, q, J = 7.1 Hz, OCH2), 5.42 (1H, s, CH),
6.19 (1H, br s, NH), 6.84 (2H, d, J = 1.8 Hz, H‐Ar), 7.03
(1H, t, J = 2.1 Hz, H‐Ar). Anal. Calcd for C19H23NO3S:
C, 66.06; H, 6.71; N, 4.05. Found: C, 67.11; H, 6.63; N,
3.94.
29765.
[21] A. Maleki, M. Rabbani, S. Shahrokh, Appl. Organometal. Chem.
2015, 29, 809.
[22] R. Kardooni, A. R. Kiasat, H. Motamedi, J. Taiwan Inst. Chem.
Engin. 2017, 81, 373.
[23] A. Khazaei, A. R. Moosavi‐Zare, H. Afshar‐Hezarkhani, V.
Khakyzadeh, RSC Adv. 2014, 4, 32142.
[24] D. Li, J. Wang, F. Chen, H. Jing, RSC Adv. 2017, 7, 4237.
ACKNOWLEDGEMENTS
[25] A. Maleki, M. Kamalzare, M. Aghaei, J. Nanostruct. Chem.
2015, 5, 95.
The authors gratefully acknowledge the partial support
from the Research Council of the Iran University of
Science and Technology.
[26] A. Maleki, A. R. Akbarzade, A. R. Bhat, J. Nanostruct. Chem.
2017, 7, 309.
[27] A. Maleki, Tetrahedron 2012, 68, 7827.
ORCID
How to cite this article: Maleki A, Hamidi N,
Maleki S, Rahimi J. Surface modified SPIONs‐
Cr(VI) ions‐immobilized organic‐inorganic hybrid
as a magnetically recyclable nanocatalyst for rapid
synthesis of polyhydroquinolines under solvent‐free
conditions at room temperature. Appl Organometal
REFERENCES
[1] A. Maleki, R. Paydar, React. Funct. Polym. 2016, 109, 120.
[2] I. Pastan, M. M. Gottesman, N. Engl. J. Med. 1987, 316, 1388.
[3] B. Loev, K. M. Snader, J. Org. Chem. 1965, 30, 1914.